Search Within

Isabelle C Riviere

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (28)
  2. Journal Article (17)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Department of Medicine (47)
  2. Hematologic Malignancies, Division of (47)
  3. Sloan Kettering Institute Postdocs (47)
  4. GSK Faculty (45)
  5. Center for Hematologic Malignancies (44)
  6. Hematologic Malignancies Research (44)

More Groups

People
  1. Michel Sadelain (38)
  2. Xiuyan Wang (23)
  3. Jorge Mansilla-Soto (18)
  4. Jae Park (16)
  5. Sjoukje van der Stegen (12)
  6. Renier Brentjens (11)

More People

Years
  1. 2025 (2)
  2. 2023 (5)
  3. 2022 (8)
  4. 2021 (6)
  5. 2020 (3)
  6. 2019 (6)

More Years

Publications
  1. Blood (15)
  2. Molecular Therapy (5)
  3. Cancer Discovery (2)
  4. Cancer Research (2)
  5. Cell Stem Cell (2)
  6. Cytotherapy (2)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Nature Publishing Group (13)
  3. American Association for Cancer Research (4)
  4. Cell Press (3)
  5. American Society of Clinical Oncology (2)
  6. Elsevier Inc. (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Journal Article

    Shahid, S.; Prockop, S. E.; Flynn, G. C.; Mauguen, A.; White, C. O.; Bieler, J.; McAvoy, D.; Hosszu, K.; Cancio, M. I.; Jakubowski, A. A.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cooperative CAR targeting to selectively eliminate AML and minimize escape
    Journal Article

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; de Stanchina, E.; Lopez, M.; Ng, M. R.; Fraser, K.; Subklewe, M.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Characterizing the relationship between cellular kinetics and response to support dosing recommendations for Cd19-targeted 19(T2)28z1xx cell therapy
    Meeting Abstract

    Li, J.; Singh, R.; Dey, A.; Sellner, L.; Liu, R.; Dash, A.; Park, J.; Palomba, M.; Mansilla-Soto, J.; Senechal, B.; more...
    Clinical Pharmacology & Therapeutics (2023)

    Fulltext@MSK | Save
  • Programming CAR T cell tumor recognition: Tuned antigen sensing and logic gating
    Review

    Hamieh, M.; Mansilla-Soto, J.; Rivière, I.; Sadelain, M.
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Unraveling barriers to iPSC-derived CAR-T cell differentiation
    Editorial

    van der Stegen, S. J. C.; Rivière, I.
    Cell Stem Cell (2023)

    Fulltext@MSK | Save
  • The development of allogeneic tips-derived TCR(-)CAR(+) CD8αβ T cells
    Meeting Abstract

    van der Stegen, S. J. C.; Petrovic, R. M.; Lindenbergh, P. L.; Diop, M. P.; Alexeeva, V.; Xie, H.; Clarke, R.; Valamehr, B.; Rivière, I.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; Rivière, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1XX CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Rivière, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Bermudez, V. P.; Cathcart, E. R.; Liotta, K.; Joseph, J.; more...
    Blood (2022)

    Fulltext@MSK | Save